Developer docs
API playgroundTry for free, no card

Search company profiles

Arc Bio LLC

Full company profile

uuid0003nkl

Namestring
Arc Bio LLC
Legal namestring
Arc Bio LLC
Websiteurl
arcbio.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Arc Bio LLC is a privately held life sciences company founded in July 2018 and headquartered in Menlo Park, California, with an additional office in the Metro Boston area. The company operates as a subsidiary of EdenRoc Sciences, a holding company whose portfolio also includes Cantata Bio and Dovetail Genomics. Arc Bio develops metagenomic next-generation sequencing (mNGS) tools targeting infectious disease applications, with its flagship platform branded as Omni ID™ (and previously marketed as the Galileo Pathogen Solution and Galileo ONE).

The company's product suite consists of (i) SeqPrep reagent kits — including ExoBiome-DNA for microbial enrichment, Standards and Controls for QC, and DNA/RNA library prep reagents configurable for up to 24 libraries; (ii) the Lumens cloud-based WebApp, powered by a proprietary graph-based sequence aligner and signal-scoring system that automates microbial detection and QC reporting; and (iii) customizable APIs for programmatic access. The platform is compatible with Illumina NextSeq and NovaSeq sequencers, claims sample-to-results in under 30 hours, detects more than 1,400 microbial species without targeted primers/probes, and is positioned as covering more than 99% of known human pathogens from a single sample across parallel DNA and RNA workflows. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow consulting for biopharma and research customers.

Arc Bio generates revenue through sale of reagent kits (unit pricing, pay-as-you-go), Lumens software tokens bundled with kits or sold separately (recurring software usage), and professional services for bespoke workflow development. Go-to-market is primarily direct sales via the company website and phone/email contact, supplemented by conference participation (e.g., IDWeek, Conference Amp) and peer-reviewed publication-driven scientific marketing. The platform targets clinical microbiology labs, academic and commercial research labs, and biopharma companies, and is currently sold as a research-use-only (RUO) product.

Short descriptiontext

Arc Bio LLC develops the Omni ID mNGS platform — reagent kits, a cloud-based bioinformatics WebApp (Lumens), and custom metagenomics services — for clinical microbiology, research, and biopharma labs performing broad-range microbial detection on Illumina sequencers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
metagenomic sequencing, microbial detection, NGS reagent kits, bioinformatics software, infectious disease diagnostics
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAJABAC
Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS)
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Diagnostics
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1mNGS Reagent Kits
TypeOne Time License
Description

Sale of reagent kits for mNGS library preparation including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards. Kits are available in multiple configurations to supplement existing workflows or deploy complete Omni ID solutions. Each kit processes up to 24 libraries.

arcbio.com
2Lumens Software Tokens
TypeSubscription Recurring
Description

Cloud-based WebApp processing credits (Lumens Tokens) for library analysis. Tokens are included with SeqPrep reagent kits or available separately. Provides file processing, QC analysis, and microbial detection reporting.

arcbio.com
3Custom NGS Services
TypeProfessional Services
Description

Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions. Includes custom metagenomics solutions, biomarker discovery, workflow establishment counseling, and automation services.

arcbio.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Omni ID reagent kits available in multiple configurations for supplementing existing workflows or deploying complete solutions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Kits sold in configurations for 24 library preparations. SeqPrep-DNA and SeqPrep-RNA include Lumens Token credits. ExoBiome-DNA sold separately for microbial enrichment.

arcbio.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Omni ID™
Description

Proprietary target enrichment platform for next-generation sequencing applications.

arcbio.com
+2 more records
Core offering1 text field

Arc Bio LLC provides the Omni ID™ metagenomic Next-Generation Sequencing (mNGS) platform, which combines reagent kits for sample and library preparation (SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards) with the Lumens cloud-based WebApp for automated microbial detection and QC reporting. The platform enables clinical and research labs to perform unbiased, broad-range microbial detection of over 1,400 species from a single sample without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Sample-to-results in less than 30 hours
+2 more records
Product overview1 text field

Arc Bio LLC offers the Omni ID™ mNGS platform, a comprehensive metagenomic Next-Generation Sequencing solution consisting of the core Omni ID™ Platform, SeqPrep reagent kits (including ExoBiome-DNA for microbial enrichment and Standards/Controls for quality assurance), and the Lumens cloud-based bioinformatics WebApp for automated microbial detection and reporting. The platform provides sample-to-results in under 30 hours, detecting over 1,400 species of microorganisms from a single sample without need for targeted primers/probes. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow establishment consulting to support research, clinical, and biopharma applications.

Product and service6 records
1Omni ID™ Platform
CategoryMetagenomic sequencing platform
Description

Metagenomic NGS (mNGS) platform enabling broad-range, single-test, multiple-indication microbial detection with flexible deployed capability for clinical and research labs. Detects over 1,400 species without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.

2Omni ID™ SeqPrep
CategoryNGS reagent kits
Description

Kit-based sample preparation reagents for NGS library prep, including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA for microbial enrichment, Standards and Controls for quality metrics, and barcode adapters for multiplexing up to 24 libraries per kit. Each kit processes up to 24 libraries.

3Omni ID™ Lumens
CategoryBioinformatics software
Description

Cloud-based mNGS bioinformatics WebApp that automates microbial sequence detection, QC analysis, and reporting with proprietary graph-based sequence alignment. Provides file processing, QC analysis, and microbial detection reporting through Lumens Tokens (processing credits) that are included with SeqPrep reagent kits or available separately, with access also available via customizable APIs.

4Custom Metagenomics Services
CategoryProfessional services
Description

Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions across research, healthcare, diagnostics, and biopharma applications, including custom workflow development, validation, automation, and shipping of customized solutions.

5Biomarker Discovery Services
CategoryProfessional services
Description

Services for biomarker discovery using metagenomics data to aid in patient selection, early detection, disease monitoring, and prediction of treatment efficacy.

6Workflow Establishment Consulting
CategoryConsulting services
Description

Counsel on establishing metagenomic workflows, including quality metrics, software solutions, and lab setup services.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Karius offers a clinical mNGS blood test for infectious disease diagnostics, the most direct competitor to Arc Bio's Omni ID platform. Both target broad pathogen detection from liquid samples such as plasma, addressing the same hospital microbiology use cases.

TypeBroad incumbent
Description

Illumina acquired IDbyDNA and is a broad incumbent in sequencing and metagenomics, while also being the platform on which Arc Bio's Omni ID runs. It offers overlapping DRAGEN metagenomics pipelines and is both a critical partner and a competitive threat.

TypeDirect peer
Description

CosmosID provides a curated microbial genomics database and cloud-based bioinformatics for mNGS analysis, directly comparable to Arc Bio's Lumens reference database and graph-based aligner approach.

TypeBroad incumbent
Description

bioMérieux is a major clinical microbiology and in-vitro diagnostics incumbent expanding into genomics-based pathogen detection, overlapping with Arc Bio's clinical microbiology lab use cases.

TypeBroad incumbent
Description

Qiagen offers sample-preparation kits (QIAamp, QIAseq) plus CLC Genomics Workbench bioinformatics, spanning both halves of Arc Bio's wet-lab + cloud-software stack for molecular microbiology and genomics labs.

6DNASTAR
TypeEmerging player
Description

DNASTAR provides genomics analysis software (Lasergene) used for sequence assembly and microbial analysis, comparable to Arc Bio's Lumens as a sequence analysis and interpretation platform for research and clinical labs.

TypeBroad incumbent
Description

Thermo Fisher provides Ion Torrent sequencing, microbiology reagents, and bioinformatics tools that overlap with Arc Bio's mNGS workflow, serving similar clinical and research customers.

TypeBroad incumbent
Description

Roche is a major IVD incumbent with microbiology and molecular diagnostics franchises, representing a potential clinical channel competitor as hospitals consolidate infectious-disease testing around large diagnostics vendors.

TypeEmerging player
Description

Clear Labs offers an automated NGS-based pathogen detection platform for food safety and clinical microbiology, comparable as an emerging metagenomics play targeting routine lab adoption of sequencing workflows.

TypeEmerging player
Description

T2 Biosystems provides rapid molecular diagnostics for infectious disease, a comparable emerging player in the clinical microbiology space where speed-to-result and broad detection are key value drivers, similar to Arc Bio's <30-hour mNGS positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arc Bio LLC

Molecular Diagnosticsarcbio.com

Arc Bio LLC develops the Omni ID mNGS platform — reagent kits, a cloud-based bioinformatics WebApp (Lumens), and custom metagenomics services — for clinical microbiology, research, and biopharma labs performing broad-range microbial detection on Illumina sequencers.

What Arc Bio LLC does

Arc Bio LLC is a privately held life sciences company founded in July 2018 and headquartered in Menlo Park, California, with an additional office in the Metro Boston area. The company operates as a subsidiary of EdenRoc Sciences, a holding company whose portfolio also includes Cantata Bio and Dovetail Genomics. Arc Bio develops metagenomic next-generation sequencing (mNGS) tools targeting infectious disease applications, with its flagship platform branded as Omni ID™ (and previously marketed as the Galileo Pathogen Solution and Galileo ONE).

The company's product suite consists of (i) SeqPrep reagent kits — including ExoBiome-DNA for microbial enrichment, Standards and Controls for QC, and DNA/RNA library prep reagents configurable for up to 24 libraries; (ii) the Lumens cloud-based WebApp, powered by a proprietary graph-based sequence aligner and signal-scoring system that automates microbial detection and QC reporting; and (iii) customizable APIs for programmatic access. The platform is compatible with Illumina NextSeq and NovaSeq sequencers, claims sample-to-results in under 30 hours, detects more than 1,400 microbial species without targeted primers/probes, and is positioned as covering more than 99% of known human pathogens from a single sample across parallel DNA and RNA workflows. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow consulting for biopharma and research customers.

Arc Bio generates revenue through sale of reagent kits (unit pricing, pay-as-you-go), Lumens software tokens bundled with kits or sold separately (recurring software usage), and professional services for bespoke workflow development. Go-to-market is primarily direct sales via the company website and phone/email contact, supplemented by conference participation (e.g., IDWeek, Conference Amp) and peer-reviewed publication-driven scientific marketing. The platform targets clinical microbiology labs, academic and commercial research labs, and biopharma companies, and is currently sold as a research-use-only (RUO) product.

Arc Bio LLC firmographics

Firmographics
Name
Arc Bio LLC
Legal name
Arc Bio LLC
Website
https://arcbio.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Arc Bio LLC develops the Omni ID mNGS platform — reagent kits, a cloud-based bioinformatics WebApp (Lumens), and custom metagenomics services — for clinical microbiology, research, and biopharma labs performing broad-range microbial detection on Illumina sequencers.
Ownership category
akta.pro rank

Arc Bio LLC industry classification

Industry
Product category
Molecular Diagnostics
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAJABAC
Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS)
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response

Keywords

  • Metagenomic sequencing
  • Microbial detection
  • NGS reagent kits
  • Bioinformatics software
  • Infectious disease diagnostics

Where Arc Bio LLC is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Arc Bio LLC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. mNGS Reagent Kits: Sale of reagent kits for mNGS library preparation including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards. Kits are available in multiple configurations to supplement existing workflows or deploy complete Omni ID solutions. Each kit processes up to 24 libraries.
  2. Lumens Software Tokens: Cloud-based WebApp processing credits (Lumens Tokens) for library analysis. Tokens are included with SeqPrep reagent kits or available separately. Provides file processing, QC analysis, and microbial detection reporting.
  3. Custom NGS Services: Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions. Includes custom metagenomics solutions, biomarker discovery, workflow establishment counseling, and automation services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goOmni ID reagent kits available in multiple configurations for supplementing existing workflows or deploying complete solutions

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Arc Bio LLC product offering

Product offering

Core offering

Arc Bio LLC provides the Omni ID™ metagenomic Next-Generation Sequencing (mNGS) platform, which combines reagent kits for sample and library preparation (SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards) with the Lumens cloud-based WebApp for automated microbial detection and QC reporting. The platform enables clinical and research labs to perform unbiased, broad-range microbial detection of over 1,400 species from a single sample without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.

Product overview

Arc Bio LLC offers the Omni ID™ mNGS platform, a comprehensive metagenomic Next-Generation Sequencing solution consisting of the core Omni ID™ Platform, SeqPrep reagent kits (including ExoBiome-DNA for microbial enrichment and Standards/Controls for quality assurance), and the Lumens cloud-based bioinformatics WebApp for automated microbial detection and reporting. The platform provides sample-to-results in under 30 hours, detecting over 1,400 species of microorganisms from a single sample without need for targeted primers/probes. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow establishment consulting to support research, clinical, and biopharma applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Omni ID™: Proprietary target enrichment platform for next-generation sequencing applications.
  • Galileo ONE
  • Lumens

Products and services

  • Omni ID™ Platform Metagenomic NGS (mNGS) platform enabling broad-range, single-test, multiple-indication microbial detection with flexible deployed capability for clinical and research labs. Detects over 1,400 species without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.
  • Omni ID™ SeqPrep Kit-based sample preparation reagents for NGS library prep, including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA for microbial enrichment, Standards and Controls for quality metrics, and barcode adapters for multiplexing up to 24 libraries per kit. Each kit processes up to 24 libraries.
  • Omni ID™ Lumens Cloud-based mNGS bioinformatics WebApp that automates microbial sequence detection, QC analysis, and reporting with proprietary graph-based sequence alignment. Provides file processing, QC analysis, and microbial detection reporting through Lumens Tokens (processing credits) that are included with SeqPrep reagent kits or available separately, with access also available via customizable APIs.
  • Custom Metagenomics Services Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions across research, healthcare, diagnostics, and biopharma applications, including custom workflow development, validation, automation, and shipping of customized solutions.
  • Biomarker Discovery Services Services for biomarker discovery using metagenomics data to aid in patient selection, early detection, disease monitoring, and prediction of treatment efficacy.
  • Workflow Establishment Consulting Counsel on establishing metagenomic workflows, including quality metrics, software solutions, and lab setup services.

Quantifiable outcome

  • Sample-to-results in less than 30 hours
  • +2 more outcomes

Companies that use Arc Bio LLC

Customer profile

Segments3 records

Ideal customer profiles3 records

Arc Bio LLC technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Arc Bio LLC partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Arc Bio LLC competitors and assessment

Company assessment

Direct peers

  • Karius: Karius offers a clinical mNGS blood test for infectious disease diagnostics, the most direct competitor to Arc Bio's Omni ID platform. Both target broad pathogen detection from liquid samples such as plasma, addressing the same hospital microbiology use cases.
  • CosmosID: CosmosID provides a curated microbial genomics database and cloud-based bioinformatics for mNGS analysis, directly comparable to Arc Bio's Lumens reference database and graph-based aligner approach.

Broad incumbents

  • Illumina: Illumina acquired IDbyDNA and is a broad incumbent in sequencing and metagenomics, while also being the platform on which Arc Bio's Omni ID runs. It offers overlapping DRAGEN metagenomics pipelines and is both a critical partner and a competitive threat.
  • bioMérieux: bioMérieux is a major clinical microbiology and in-vitro diagnostics incumbent expanding into genomics-based pathogen detection, overlapping with Arc Bio's clinical microbiology lab use cases.
  • Qiagen: Qiagen offers sample-preparation kits (QIAamp, QIAseq) plus CLC Genomics Workbench bioinformatics, spanning both halves of Arc Bio's wet-lab + cloud-software stack for molecular microbiology and genomics labs.
  • Thermo Fisher Scientific: Thermo Fisher provides Ion Torrent sequencing, microbiology reagents, and bioinformatics tools that overlap with Arc Bio's mNGS workflow, serving similar clinical and research customers.
  • Roche Diagnostics: Roche is a major IVD incumbent with microbiology and molecular diagnostics franchises, representing a potential clinical channel competitor as hospitals consolidate infectious-disease testing around large diagnostics vendors.

Emerging players

  • DNASTAR: DNASTAR provides genomics analysis software (Lasergene) used for sequence assembly and microbial analysis, comparable to Arc Bio's Lumens as a sequence analysis and interpretation platform for research and clinical labs.
  • Clear Labs: Clear Labs offers an automated NGS-based pathogen detection platform for food safety and clinical microbiology, comparable as an emerging metagenomics play targeting routine lab adoption of sequencing workflows.
  • Caribou Biosciences (now part of the public clinical mNGS ecosystem via T2 Biosystems adjacency): T2 Biosystems provides rapid molecular diagnostics for infectious disease, a comparable emerging player in the clinical microbiology space where speed-to-result and broad detection are key value drivers, similar to Arc Bio's <30-hour mNGS positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Arc Bio LLC social profiles

Digital presence

Arc Bio LLC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arc Bio LLC leadership team

Management profile

Number of profiles

Profiles5 records

Arc Bio LLC funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arc Bio LLC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arc Bio LLC

What does Arc Bio LLC do?

Arc Bio LLC provides the Omni ID™ metagenomic Next-Generation Sequencing (mNGS) platform, which combines reagent kits for sample and library preparation (SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards) with the Lumens cloud-based WebApp for automated microbial detection and QC reporting. The platform enables clinical and research labs to perform unbiased, broad-range microbial detection of over 1,400 species from a single sample without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.

Is Arc Bio LLC a public or private company?

Arc Bio LLC is a private company. It is classified as corporate owned and is currently operating.

When was Arc Bio LLC founded?

Arc Bio LLC was founded in 2018. It employs 1 to 10 people.

Where is Arc Bio LLC based?

Arc Bio LLC is headquartered in Cambridge, United States, in the North America region.

How does Arc Bio LLC make money?

Three revenue lines are on record. mNGS Reagent Kits are the primary driver. The others are lumens Software Tokens and custom NGS Services.

Who are Arc Bio LLC's main competitors?

Direct peers on record are Karius and CosmosID. Broad incumbents are Illumina, bioMérieux, Qiagen, Thermo Fisher Scientific and Roche Diagnostics. Emerging players are DNASTAR, Clear Labs and Caribou Biosciences (now part of the public clinical mNGS ecosystem via T2 Biosystems adjacency).

Does Arc Bio LLC have an API?

Yes. Customizable APIs are available for the Omni ID platform. Access and library processing tokens for Omni ID Lumens are included through the user-friendly web app and customizable APIs.

What industry is Arc Bio LLC in?

Arc Bio LLC's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireArc Bio Announces Early Access Program for Galileo™ ONE, Bringing Metagenomic NGS Directly to Clinical Microbiology LabsArc Bio announced the launch of an Early Access Program for its Galileo™ ONE research-use-only metagenomic sequencing workflow, designed to enable microbiology labs to perform microbial detection and quantification without in-house bioinformatics expertise. The platform leverages the Illumina NGS technology to detect over 6,000 microbial strains from a single plasma sample, with initial applications focused on COVID-19 research and oncology detection. The company is seeking partnerships with leading institutions to accelerate metagenomics adoption in disease areas with high unmet need.PR NewswireArc Bio Unveils its Galileo™ Pathogen Solution: A Fully Integrated NGS-based Metagenomics Platform with a Revolutionized Design for Pathogen DetectionArc Bio unveiled its Galileo™ Pathogen Solution, a comprehensive next-generation sequencing test for monitoring post-transplant patients at high risk for viral infections, at the 29th European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam on April 11, 2019. The test can detect over 350 viral strains including CMV, EBV, BKV, and hADV in a single comprehensive assay, compared to existing qPCR technology that can only detect one virus per test, and will initially launch as a Research Use Only product in May 2019. With approximately 30 percent of the 57,000 annual U.S. transplant recipients developing viral infections costing an average of $400,000 per patient to treat, Arc Bio aims to provide better patient care while reducing healthcare costs.